NCT02770417View on ClinicalTrials.gov

Oral β-Alanine Supplementation in Patients With COPD

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DIETARY_SUPPLEMENT

beta-alanine

Patients receive beta-alanine

DIETARY_SUPPLEMENT

placebo

Patients receive placebo

OTHER

control

Healthy controls will be assessed to compare baseline muscle carnosine levels

Trial Locations (1)

3500

Jessa Ziekenhuis (ReGo), Hasselt

All Listed Sponsors
collaborator

Jessa Hospital

OTHER

lead

Hasselt University

OTHER

NCT02770417 - Oral β-Alanine Supplementation in Patients With COPD | Biotech Hunter | Biotech Hunter